CSBR CHAMPIONS ONCOLOGY, INC.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $65.5M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $50.0K | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $190.0K | $0 |
| 2023-Q4 | $155.8K | $0 |
| 2024-Q1 | $96.0K | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$491.8K26 buy days
Sold$00 sell days
Net insider flow+$491.8Knet buying · 5 years
Latest trade2024-01-12Mendelson Daniel Newman
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2024-01-12 | Buy | Mendelson Daniel Newman | Director | 1,000 | $6.50 | $6.5K | 1 |
| 2024-01-11 | Buy | Mendelson Daniel Newman | Director | 2,000 | $6.27 | $12.5K | 1 |
| 2024-01-10 | Buy | Mendelson Daniel Newman | Director | 2,944 | $6.31 | $18.6K | 1 |
| 2024-01-09 | Buy | Mendelson Daniel Newman | Director | 3,000 | $6.25 | $18.8K | 1 |
| 2024-01-08 | Buy | Mendelson Daniel Newman | Director | 1,000 | $6.15 | $6.2K | 1 |
| 2024-01-05 | Buy | Mendelson Daniel Newman | Director | 2,000 | $6.09 | $12.2K | 1 |
| 2024-01-04 | Buy | Mendelson Daniel Newman | Director | 3,000 | $6.12 | $18.4K | 1 |
| 2024-01-03 | Buy | Mendelson Daniel Newman | Director | 500 | $5.83 | $2.9K | 1 |
| 2023-12-21 | Buy | Mendelson Daniel Newman | Director | 2,500 | $4.92 | $12.3K | 1 |
| 2023-12-20 | Buy | Mendelson Daniel Newman | Director | 2,100 | $4.82 | $10.1K | 1 |
| 2023-12-19 | Buy | Mendelson Daniel Newman | Director | 5,000 | $4.75 | $23.8K | 1 |
| 2023-10-11 | Buy | Mendelson Daniel Newman | Director | 5,000 | $6.40 | $32.0K | 1 |
| 2023-10-10 | Buy | Mendelson Daniel Newman | Director | 1,100 | $6.41 | $7.1K | 1 |
| 2023-10-06 | Buy | Mendelson Daniel Newman | Director | 1,530 | $6.48 | $9.9K | 1 |
| 2023-10-05 | Buy | Mendelson Daniel Newman | Director | 2,000 | $6.47 | $12.9K | 1 |
| 2023-10-04 | Buy | Mendelson Daniel Newman | Director | 5,000 | $6.40 | $32.0K | 1 |
| 2023-10-03 | Buy | Mendelson Daniel Newman | Director | 2,500 | $6.30 | $15.8K | 1 |
| 2023-09-29 | Buy | Mendelson Daniel Newman | Director | 4,000 | $6.16 | $24.6K | 1 |
| 2023-09-28 | Buy | Mendelson Daniel Newman | Director | 5,000 | $6.22 | $31.1K | 1 |
| 2023-09-27 | Buy | Mendelson Daniel Newman | Director | 1,500 | $5.95 | $8.9K | 1 |
| 2023-09-26 | Buy | Mendelson Daniel Newman | Director | 5,000 | $5.65 | $28.2K | 1 |
| 2023-09-22 | Buy | Mendelson Daniel Newman | Director | 3,812 | $5.50 | $21.0K | 1 |
| 2023-09-21 | Buy | Mendelson Daniel Newman | Director | 5,000 | $5.51 | $27.6K | 1 |
| 2023-09-20 | Buy | Mendelson Daniel Newman | Director | 4,018 | $5.51 | $22.1K | 1 |
| 2023-09-19 | Buy | Mendelson Daniel Newman | Director | 5,000 | $5.28 | $26.4K | 1 |
| 2023-03-17 | Buy | Morris Ronnie | CEO | 12,382 | $4.04 | $50.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Mendelson Daniel Newman | Director | $441.8K | $0 | 2024-01-12 |
| Morris Ronnie | CEO | $50.0K | $0 | 2023-03-17 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.